title: Bilateral Warthin tumor in psoriatic patients in therapy with multiple immunosuppressive therapy.
abstract: Anti-TNFα drugs have strongly changed the way in which we deal with moderate and severe psoriasis. However, it is debatable whether biological drugs could increase the risk of developing cancer. The correlation between anti-TNFα drugs and lymphomas is well-known and is reported in all the technical details of biologic drugs. However, the association between anti-TNFα agents and solid tumors is still controversial. The authors report a case of bilateral salivary gland tumor in a psoriatic patient treated with several immunosuppressive therapies including anti-TNFα inhibitors.
authors: IRCCS A.O.U. San Martino-IST, Di.S.Sal, Section of Dermatology, University of Genoa, Italy.
authors: M
authors: M
authors: Burlando
authors: IRCCS A.O.U. San Martino-IST, Di.S.Sal, Section of Dermatology, University of Genoa, Italy emanuele.cozzani@unige.it.
authors: E
authors: E
authors: Cozzani
authors: IRCCS A.O.U. San Martino-IST, Di.S.Sal, Section of Dermatology, University of Genoa, Italy.
authors: C
authors: C
authors: Chinazzo
authors: IRCCS A.O.U. San Martino-IST, Di.S.Sal, Section of Dermatology, University of Genoa, Italy.
authors: M
authors: M
authors: Larosa
authors: Department of Anatomic Pathology, IRCCS A.O.U. San Martino-IST, Genoa, Italy.
authors: M
authors: M
authors: Boggio
authors: IRCCS A.O.U. San Martino-IST, Di.S.Sal, Section of Dermatology, University of Genoa, Italy.
authors: A
authors: A
authors: Parodi
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D009396:Wilms Tumor / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha
keywords: TNFα therapy; Warthin tumor; psoriasis